Literature DB >> 31211328

Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the Test.

David Wolk1, Stephen Salloway2, Brad Dickerson3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31211328     DOI： 10.1001/jama.2019.7534

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis.

Authors:  Tim West; Kristopher M Kirmess; Matthew R Meyer; Mary S Holubasch; Stephanie S Knapik; Yan Hu; John H Contois; Erin N Jackson; Scott E Harpstrite; Randall J Bateman; David M Holtzman; Philip B Verghese; Ilana Fogelman; Joel B Braunstein; Kevin E Yarasheski
Journal:  Mol Neurodegener       Date:  2021-05-01       Impact factor: 14.195

2.  Adding cognition to AT(N) models improves prediction of cognitive and functional decline.

Authors:  Deirdre M O'Shea; Kelsey R Thomas; Breton Asken; Athene K W Lee; Jennifer D Davis; Paul F Malloy; Stephen P Salloway; Stephen Correia
Journal:  Alzheimers Dement (Amst)       Date:  2021-03-31

3.  Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.

Authors:  Mohammad Javad Sedghizadeh; Hadi Hojjati; Kiana Ezzatdoost; Hamid Aghajan; Zahra Vahabi; Heliya Tarighatnia
Journal:  PLoS One       Date:  2020-12-15       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.